AIDS in Africa: Evidence for heterosexual transmission of the human immunodeficiency virus

  • Thomas C. Quinn


Since its initial recognition in 1981, acquired immunodeficiency syndrome (AIDS) has become a global epidemic. Nearly 40,000 cases have been reported from over 85 countries on five different continents. Presently, an estimated 5–10 million people worldwide have been infected with the causative agent, referred to as the human immunodeficiency virus (HIV).1,2 From natural history studies, it can be expected that at least 10–30% of these HIV-infected individuals may develop AIDS within the next three years,3–6 resulting in a cumulative number of more than one million cases of AIDS worldwide by 1990. With the present lack of effective curative therapy or a vaccine, this disease now represents one of the most serious epidemics of the century.


Acquire Immunodeficiency Syndrome Intravenous Drug User Lifetime Sexual Partner Heterosexual Transmission York City Department 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Mahler H, Assad F: The World Health Organization’s programme on AIDS. Abstracts of the Second International Conference on AIDS, Paris, France, June 23–25, 1986, p 5.Google Scholar
  2. 2.
    Coffin J, Haase A, Levy JA, et al: Human immunodeficiency viruses [letter]. Science 1986; 232:697.PubMedCrossRefGoogle Scholar
  3. 3.
    Curran JW, Morgan WM, Hardy AM, et al: The epidemiology of AIDS: Current status and future prospects. Science 1985; 229:1352–1357.PubMedCrossRefGoogle Scholar
  4. 4.
    Melbye M: The natural history of human T lymphotropic virus-Ill infection: The cause of AIDS. Br Med J 1986; 292:5–12.CrossRefGoogle Scholar
  5. 5.
    Jaffe HW, Darrow WW, Echenberg DF, et al: The acquired immunodeficiency syndrome in a cohort of homosexual men: A six-year follow-up study. Ann Intern Med 1985; 103:210–214.PubMedGoogle Scholar
  6. 6.
    Goedert JJ, Biggar RJ, Weiss SH, et al: Three-year incidence of AIDS in five cohorts of HTLV-III infected risk group members. Science 1986; 231:922–995.CrossRefGoogle Scholar
  7. 7.
    Clumeck N, Sonnet J, Taelman H, et al: Acquired immunodeficiency syndrome in African patients. N Engl J Med 1984; 210:492–497.CrossRefGoogle Scholar
  8. 8.
    Brunet JB, Ancelle R: Update: Acquired immunodeficiency syndrome—Europe. MMWR 1985; 34:583–589.Google Scholar
  9. 9.
    World Health Organization: Acquired immunodeficiency syndrome (AIDS): Situation in Europe as of 31 December 1985. Wkly Epidemiol Rec 1986;61:125–128.Google Scholar
  10. 10.
    Piot P, Quinn TC, Taelman H, et al: Acquired immunodeficiency syndrome in a heterosexual population in Zaire. Lancet 1984; 2:65–69.PubMedCrossRefGoogle Scholar
  11. 11.
    Van de Perre P, Rouvroy D, Lepage P, et al: Acquired immunodeficiency syndrome in Rwanda. Lancet 1984; 2:62–65.PubMedCrossRefGoogle Scholar
  12. 12.
    Quinn TC, Mann JM, Curran JW, et al: AIDS in Africa: An epidemiological paradigm. Science 1986; 234:955–963.PubMedCrossRefGoogle Scholar
  13. 13.
    Kreiss JK, Koech D, Plummer FA, et al: AIDS virus infection in Nairobi prostitutes: Spread of the epidemic to East Africa. N Engl J Med 1986; 314:414–418.PubMedCrossRefGoogle Scholar
  14. 14.
    Mann JM, Francis H, Quinn T, et al: Surveillance for AIDS in a Central African city: Kinshasa, Zaire. JAMA 1986; 255:3255–3259.PubMedCrossRefGoogle Scholar
  15. 15.
    Melbye M, Njelesani EK, Bayley A, et al: Evidence for heterosexual transmission and clinical manifestations of human immunodeficiency virus infection and related conditions in Lusaka, Zambia. Lancet 1986; 2:1113–1115.PubMedCrossRefGoogle Scholar
  16. 16.
    Aral SO, Holmes KK: Epidemiology of sexually transmitted diseases, in Holmes KK, Mardh PA, Sparling PF, et al (eds): Sexually Transmitted Diseases. New York, McGraw-Hill, pp 127–141.Google Scholar
  17. 17.
    Clumeck N, Robert-Guroff M, Van de Perre P, et al: Seroepidemiological studies of HTLV-III antibody prevalence among selected groups of heterosexual Africans. JAMA 1985;254:2599–2602.PubMedCrossRefGoogle Scholar
  18. 18.
    Clumeck N, Van de Perre P, Carael M, et al: Heterosexual promiscuity among African patients with AIDS. N Engl J Med 1985; 313:182.Google Scholar
  19. 19.
    Van de Perre P, Clumeck N, Carael M, et al: Female prostitutes: A risk group for infection with human T-cell lymphotropic virus type III. Lancet 1985;2:524–527.PubMedGoogle Scholar
  20. 20.
    Mann JM, Francis H, Davachi F, et al: HTLV-III/LAV seroprevalence in pediatric in-patients 2–14 years old in Kinshasa, Zaire. J Pediatrics 1986; 78:673–677.Google Scholar
  21. 21.
    Mann JM, Francis H, Quinn TC, et al: HTLV-III/LAV seroprevalence among hospital workers in Kinshasa, Zaire: Lack of association with occupational exposure. JAMA 1986;256:3099–3102.PubMedCrossRefGoogle Scholar
  22. 22.
    Mann JM, Francis H, Quinn TC, et al: Role of blood transfusions in transmission of HTLV-III infection in Zaire. Am J Pub Health (in press).Google Scholar
  23. 23.
    Mann JM, Francis H, Davachi F, et al: Risk factors for human immunodeficiency virus seropositivity among children 1–24 months old in Kinshasa, Zaire. Lancet 1986;2:654–657.PubMedCrossRefGoogle Scholar
  24. 24.
    Zuckerman AJ: AIDS and insects. Br Med J 1986; 292:1094–1095.CrossRefGoogle Scholar
  25. 25.
    Mann JM, Quinn TC, Francis H: Sexual practices associated with LAV/ HTLV-III seropositivity among female prostitutes in Kinshasa, Zaire. Presented at the International Conference on AIDS, Paris, France, June 23–25, 1986.Google Scholar
  26. 26.
    Piot P, Plummer FA, Rey M, et al: Retrospective seroepidemiology of AIDS virus infection in Nairobi populations. J Infect Dis (in press).Google Scholar
  27. 27.
    Mann JM, Quinn TC, Francis H, et al: Prevalence of HTLV-III/LAV in household contacts of patients with confirmed AIDS and controls in Kinshasa, Zaire. JAMA 1986;256:721–724.PubMedCrossRefGoogle Scholar
  28. 28.
    Jonckheer T, Dab I, Van de Perre P, et al: Cluster of HTLV-III/LAV infection in an African family. Lancet 1985; 1:400–401.PubMedCrossRefGoogle Scholar
  29. 29.
    Piot P, Mann JM: Bidirectional heterosexual transmission of human immunodeficiency virus (HIV). Presented at the International Conference on AIDS, Paris, France, June 23–25, 1986.Google Scholar

Copyright information

© Medical Society of the State of New York 1989

Authors and Affiliations

  • Thomas C. Quinn
    • 1
    • 2
  1. 1.Laboratory of Immunoregulation, National Institutes of Allergy and Infectious DiseasesNational Institutes of HealthBethesdaUSA
  2. 2.Johns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations